Adenocarcinoma of the lung diagnostic study of choice
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sudarshana Datta, MD [2]
Adenocarcinoma of the Lung Microchapters |
Differentiating Adenocarcinoma of the Lung from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Adenocarcinoma of the lung diagnostic study of choice On the Web |
American Roentgen Ray Society Images of Adenocarcinoma of the lung diagnostic study of choice |
FDA on Adenocarcinoma of the lung diagnostic study of choice |
CDC on Adenocarcinoma of the lung diagnostic study of choice |
Adenocarcinoma of the lung diagnostic study of choice in the news |
Blogs on Adenocarcinoma of the lung diagnostic study of choice |
Risk calculators and risk factors for Adenocarcinoma of the lung diagnostic study of choice |
Overview
Biopsy is the diagnostic study of choice for adenocarcinoma of the lung.
Diagnostic Study of Choice
- Biopsy is helpful in the diagnosis of adenocarcinoma of the lung.
- During a biopsy, tissues or cells are removed from the body so they can be tested in a laboratory. The pathology report from the laboratory will confirm whether or not cancer cells are present in the sample. The biopsies that could be used for lung cancer are:[1]
- Fine needle aspiration (FNA)
- The doctor may use a CT scan to guide FNA to remove a small amount of tissue from a suspected lung tumour or from a lymph node in the chest.
- FNA may also be done during bronchoscopy, along with endobronchial ultrasound, to take samples of lymph nodes around the trachea and the bronchi.
- Thoracentesis may be done to remove fluid from around the lungs to see if it contains cancer cells.
- To view the biopsy findings of adenocarcinoma of the lung, please click here.
References
- ↑ Lung cancer. Canadian Cancer Society 2015.http://www.cancer.ca/en/cancer-information/cancer-type/lung/diagnosis/?region=ab#Endoscopy